Rating Change
BTIG analysts reiterated a Buy rating on Verastem, Inc. (NASDAQ:VSTM) on June 24, 2026.
reiterateNASDAQ:VSTM
BTIG Reiterates Buy Rating on Verastem, Inc. (VSTM)
Rating Change BTIG analysts reiterated a Buy rating on Verastem, Inc. (NASDAQ:VSTM) on June 24, 2026. Market Context Verastem, Inc.
Market Context
Verastem, Inc. operates in the Healthcare sector. The stock currently trades at $3.85 with a market capitalization of $571.5M.
Analyst coverage from BTIG provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Verastem, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Verastem, Inc.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jun 24, 2026 | HC Wainwright & Co. | Buy | N/A |
| Jun 24, 2026 | BTIG | Buy | N/A |
| Jun 23, 2026 | Jefferies | Buy | N/A |
| May 14, 2026 | Mizuho | Outperform | N/A |
| May 08, 2026 | BTIG | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View VSTM Stock Page
Frequently Asked Questions
What does a Buy rating mean for VSTM?
A Buy rating from BTIG reflects the analyst's outlook on Verastem, Inc. (NASDAQ:VSTM). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the VSTM forecast page.